Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rIFN-gamma 1b adjunctive treatment in candidemia
NL-OMON58911Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2024
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of interferon gamma-1b in candidemia, sponsored by Radboud University Medical Center. Started Nov 2024; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
candidemia
Beyond the preview
Go deeper on NL-OMON58911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58911.